IL107480A0 - Tnf-x ribozymes and degradation resistant mrna derivatives linked to tnf-x ribozymes - Google Patents
Tnf-x ribozymes and degradation resistant mrna derivatives linked to tnf-x ribozymesInfo
- Publication number
- IL107480A0 IL107480A0 IL10748093A IL10748093A IL107480A0 IL 107480 A0 IL107480 A0 IL 107480A0 IL 10748093 A IL10748093 A IL 10748093A IL 10748093 A IL10748093 A IL 10748093A IL 107480 A0 IL107480 A0 IL 107480A0
- Authority
- IL
- Israel
- Prior art keywords
- ribozymes
- tnf
- mrna
- degradation resistant
- derivatives linked
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97105892A | 1992-11-03 | 1992-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL107480A0 true IL107480A0 (en) | 1994-02-27 |
Family
ID=25517882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10748093A IL107480A0 (en) | 1992-11-03 | 1993-11-03 | Tnf-x ribozymes and degradation resistant mrna derivatives linked to tnf-x ribozymes |
Country Status (11)
Country | Link |
---|---|
US (2) | US5985620A (de) |
EP (1) | EP0672133B1 (de) |
JP (1) | JPH08505521A (de) |
AT (1) | ATE269405T1 (de) |
AU (1) | AU680843B2 (de) |
CA (1) | CA2148368A1 (de) |
DE (1) | DE69333550T2 (de) |
IL (1) | IL107480A0 (de) |
NZ (1) | NZ257484A (de) |
WO (1) | WO1994010301A1 (de) |
ZA (1) | ZA938208B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07509133A (ja) * | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
US5864028A (en) * | 1992-11-03 | 1999-01-26 | Gene Shears Pty. Limited | Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
US5811300A (en) * | 1992-12-07 | 1998-09-22 | Ribozyme Pharmaceuticals, Inc. | TNF-α ribozymes |
AU687479B2 (en) * | 1993-11-08 | 1998-02-26 | Ribozyme Pharmaceuticals, Inc. | Base-modified enzymatic nucleic acid |
NO180167C (no) * | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
US5700923A (en) * | 1994-09-29 | 1997-12-23 | Hybridon, Inc. | Finderons and methods of their preparation and use |
US5650502A (en) * | 1994-11-09 | 1997-07-22 | Hybridon, Inc. | Ribozyme analogs having rigid non-nucleotidic linkers |
US5545729A (en) * | 1994-12-22 | 1996-08-13 | Hybridon, Inc. | Stabilized ribozyme analogs |
EP0866865B1 (de) * | 1995-11-14 | 2002-02-06 | Vimrx Holdings, Ltd. | Chimäre oligomere mit einer rns-spaltungsaktivität |
US6046319A (en) * | 1997-10-22 | 2000-04-04 | University Technologies International, Inc. | Antisense oligodeoxynucleotides regulating expression of TNF-α |
US6080580A (en) * | 1998-10-05 | 2000-06-27 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression |
US6228642B1 (en) | 1998-10-05 | 2001-05-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression |
US6858390B2 (en) | 1998-12-31 | 2005-02-22 | Ingeneus Corporation | Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
DE19956568A1 (de) * | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
KR20000065690A (ko) * | 1999-04-08 | 2000-11-15 | 박종구 | 반응 특이성 및 안정성을 개선시킨 안티센스 올리고 뉴클레오타이드, 안티센스 dna 및 그 제조방법 |
US7829693B2 (en) * | 1999-11-24 | 2010-11-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
DE60039783D1 (de) * | 1999-12-14 | 2008-09-18 | Genentech Inc | Lfa-1 antagonisten und tnf-alpha antagonisten zur |
US8546143B2 (en) | 2001-01-09 | 2013-10-01 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
EP1478730A4 (de) * | 2002-02-20 | 2006-01-25 | Sirna Therapeutics Inc | RNA-INTERFERENZ-VERMITTELTE HEMMUNG DER EXPRESSION DER GENE FÜR DIE TNF- UND TNF-REZEPTOR-SUPERFAMILIEN UNTER VERWENDUNG VON siNA (SHORT INTERFERING NUCLEIC ACID) |
JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666848A (en) * | 1984-08-31 | 1987-05-19 | Cetus Corporation | Polypeptide expression using a portable temperature sensitive control cassette with a positive retroregulatory element |
US5107065A (en) * | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
US5149635A (en) * | 1986-09-12 | 1992-09-22 | Abbott Biotech, Inc. | Messenger RNA stabilization in animal cells |
US5254678A (en) * | 1987-12-15 | 1993-10-19 | Gene Shears Pty. Limited | Ribozymes |
EP0640688A1 (de) * | 1987-12-15 | 1995-03-01 | Gene Shears Pty. Limited | Ribozyme |
WO1991019789A1 (en) * | 1990-06-19 | 1991-12-26 | Commonwealth Scientific And Industrial Research Organisation | Endonucleases |
DE69123979T2 (de) * | 1990-10-12 | 1997-04-30 | Max Planck Gesellschaft | Abgeänderte ribozyme |
-
1993
- 1993-11-03 AU AU54120/94A patent/AU680843B2/en not_active Ceased
- 1993-11-03 IL IL10748093A patent/IL107480A0/xx unknown
- 1993-11-03 AT AT93924432T patent/ATE269405T1/de not_active IP Right Cessation
- 1993-11-03 EP EP93924432A patent/EP0672133B1/de not_active Expired - Lifetime
- 1993-11-03 US US08/428,252 patent/US5985620A/en not_active Expired - Fee Related
- 1993-11-03 ZA ZA938208A patent/ZA938208B/xx unknown
- 1993-11-03 CA CA002148368A patent/CA2148368A1/en not_active Abandoned
- 1993-11-03 JP JP6510474A patent/JPH08505521A/ja active Pending
- 1993-11-03 WO PCT/AU1993/000567 patent/WO1994010301A1/en active IP Right Grant
- 1993-11-03 DE DE69333550T patent/DE69333550T2/de not_active Expired - Fee Related
- 1993-11-03 NZ NZ257484A patent/NZ257484A/xx not_active IP Right Cessation
-
1995
- 1995-04-04 US US08/416,516 patent/US6040159A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08505521A (ja) | 1996-06-18 |
AU680843B2 (en) | 1997-08-14 |
EP0672133B1 (de) | 2004-06-16 |
ATE269405T1 (de) | 2004-07-15 |
DE69333550T2 (de) | 2005-06-23 |
ZA938208B (en) | 1995-01-03 |
DE69333550D1 (de) | 2004-07-22 |
US6040159A (en) | 2000-03-21 |
AU5412094A (en) | 1994-05-24 |
NZ257484A (en) | 1997-08-22 |
EP0672133A1 (de) | 1995-09-20 |
EP0672133A4 (de) | 1997-05-21 |
US5985620A (en) | 1999-11-16 |
WO1994010301A1 (en) | 1994-05-11 |
CA2148368A1 (en) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL107480A0 (en) | Tnf-x ribozymes and degradation resistant mrna derivatives linked to tnf-x ribozymes | |
WO1999014346A3 (en) | SENSE mRNA THERAPY | |
ATE255635T1 (de) | Polypeptid, fähig zur inhibierung der bindung zwischen menschliches il-6 und dessen rezeptor | |
ES2114786A1 (es) | Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion. | |
DE69533551D1 (de) | Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen | |
BG109433A (en) | RET (RetL) Lead for Stimulating Nerve and Rat Growth | |
ATE329030T1 (de) | Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert | |
WO2003103589A3 (en) | USE OF IL-21 IN THE TREATMENT OF CANCER AND OTHER THERAPEUTIC APPLICATIONS | |
EA200100749A1 (ru) | Синтетические пептиды, обладающие поверхностной активностью, и их применение для приготовления синтетического сурфактанта | |
DK0593901T3 (da) | Oligoribonucleotid- og ribozym-analoge med terminale 3-3- og 5-5-bindinger. | |
WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
WO2002058589A3 (en) | Agents and methods for promoting bone growth | |
PL313445A1 (en) | Grb3-3 gene, variants thereof and their use | |
ATE303818T1 (de) | Verwendung des vaskularen endothelialen wachstumsfaktors zur behandlung von erektilen dysfunktionen | |
EP0832213A4 (de) | TNF-alpha RIBOZYME, FNF-alpha RIBOZYMBINDENDE PROTEINE UND ABBAURESISTENTE mRNA DERIVATE, DIE MIT TNF-alpha RIBOZYMEN VERBUNDEN SIND | |
ATE517629T1 (de) | Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems | |
ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
WO2000044898A3 (en) | Novel agouti and agouti-related peptide analogs | |
DE60119347D1 (de) | Verwendung von chimäres il6-il6r in huntingtonskrankheit | |
DE60034874D1 (de) | Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung | |
AU3956100A (en) | Rna polymerase i transcription factor tif-ia | |
WO2000037094A3 (en) | Therapeutic applications of flint polypeptides | |
WO1999036558A3 (en) | Viral vectors encoding neurofilament heavy proteins and their use |